Cadence Pharmaceuticals, Inc. · San Diego, CA United States (NASDAQ: CADX)

Cadence Pharmaceuticals, Inc. Rankings

Company Description

Cadence Pharmaceuticals figures that if a drug had success in one area, it might do well in others. The company licenses rights to compounds and develops them for sale in untapped markets or for new indications. Cadence's sole marketed product is Ofirmev, an injectable form of  acetaminophen. Cadence licensed the drug from Bristol-Myers Squibb which markets it in Europe under the name Perfalgan. Cadence markets Ofirmev in the US for the treatment of acute pain and fever in children and adults in hospital settings. With one drug on the market, Cadence is also on the lookout for other new drugs for its sales force to carry into hospitals. 

Financials

Executives

25 executives listed for Cadence Pharmaceuticals, Inc.'s San Diego, CA location.

More Cadence Pharmaceuticals, Inc. Executives

Top Cadence Pharmaceuticals, Inc. Competitors

• Cephalon, Inc.
• Cumberland Pharmaceuticals Inc.
• Pacira Pharmaceuticals, Inc.